Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96,015,846
-
Total 13F shares
-
16,228,404
-
Share change
-
+55,145
-
Total reported value
-
$180,131,214
-
Put/Call ratio
-
67%
-
Price per share
-
$11.10
-
Number of holders
-
67
-
Value change
-
+$595,907
-
Number of buys
-
33
-
Number of sells
-
19
Institutional Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q1 2021
As of 31 Mar 2021,
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,228,404 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., 5AM Venture Management, LLC, Cormorant Asset Management, LP, BOXER CAPITAL, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Redmile Group, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
67
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.